Early tumor diagnosis

TCR sequences of the tumor are not entirely random and may be related to the pathogenesis of tumor. Combining high-throughput sequencing and bioinformatics analysis, we analyze the clonality and proportion of TCR sequences to accurately monitor anti-tumor immune responses and to make early diagnosis.
By analyzing the diversity of TCR repertoire, we can monitor the course of T cell lymphoma. We do deep sequencing for TCR repertoire to provide basis for diagnosis of T cell leukemia.


Beijing City, Changping District small town life Zhongguancun Life Science Park Road No. 8 School District No. 6 Building 4 layer


No.101 5-10-2 Cuibo Road, Chunhui Street,Dadukou District, Chongqing

Contact us

© 2017 Chongqing TCRCure Biological Technology Co Ltd. All Rights Reserved.  渝ICP备17005995号  Powered by: www.300.cnManager